We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.59B
AUM Growth
+$283M
Cap. Flow
+$228M
Cap. Flow %
14.35%
Top 10 Hldgs %
6.1%
Holding
1,532
New
540
Increased
294
Reduced
266
Closed
432

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$11.9M
2
BMO icon
Bank of Montreal
BMO
+$10.5M
3
HPQ icon
HP
HPQ
+$9.75M
4
AER icon
AerCap
AER
+$9.53M
5
ITW icon
Illinois Tool Works
ITW
+$8.27M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$8.73M
2
SYF icon
Synchrony
SYF
+$8.42M
3
CAH icon
Cardinal Health
CAH
+$7.63M
4
BRO icon
Brown & Brown
BRO
+$7.55M
5
UL icon
Unilever
UL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Financials 17.36%
3 Industrials 17.08%
4 Consumer Discretionary 12.43%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGO icon
1401
Perrigo
PRGO
$1.78B
-147,384
Closed -$4.13M
PRK icon
1402
Park National Corp
PRK
$3.67B
-4,513
Closed -$683K
PRU icon
1403
Prudential Financial
PRU
$42.2B
-22,128
Closed -$2.47M
PSMT icon
1404
Pricesmart
PSMT
$5.33B
-8,130
Closed -$714K
PSN icon
1405
Parsons
PSN
$5.15B
-9,904
Closed -$586K
PTGX icon
1406
Protagonist Therapeutics
PTGX
$9.6B
-19,015
Closed -$920K
PUMP icon
1407
ProPetro Holding
PUMP
$1.43B
-28,288
Closed -$208K
PYPL icon
1408
PayPal
PYPL
$50.5B
-55,981
Closed -$3.65M
QCRH icon
1409
QCR Holdings
QCRH
$1.71B
-7,199
Closed -$513K
QDEL icon
1410
QuidelOrtho
QDEL
$959M
-29,061
Closed -$1.02M
RCKT icon
1411
Rocket Pharmaceuticals
RCKT
$384M
-90,084
Closed -$601K
RCI icon
1412
Rogers Communications
RCI
$19.1B
-13,851
Closed -$370K
RCMT icon
1413
RCM Technologies
RCMT
$203M
-21,313
Closed -$332K
RCUS icon
1414
Arcus Biosciences
RCUS
$3.66B
-165,474
Closed -$1.3M
RELL icon
1415
Richardson Electronics
RELL
$297M
-17,362
Closed -$194K
REXR icon
1416
Rexford Industrial Realty
REXR
$8.07B
-15,199
Closed -$595K
RF icon
1417
Regions Financial
RF
$26.9B
-21,418
Closed -$465K
RGNX icon
1418
Regenxbio
RGNX
$703M
-155,887
Closed -$1.11M
RICK icon
1419
RCI Hospitality Holdings
RICK
$210M
-18,393
Closed -$790K
RNR icon
1420
RenaissanceRe
RNR
$13.2B
-11,354
Closed -$2.72M
RNW icon
1421
ReNew
RNW
$2.5B
-25,464
Closed -$150K
ROL icon
1422
Rollins
ROL
$17.8B
-23,355
Closed -$1.26M
RPRX icon
1423
Royalty Pharma
RPRX
$25.7B
-50,900
Closed -$1.58M
RTX icon
1424
RTX Corp
RTX
$302B
-15,395
Closed -$2.04M
RVTY icon
1425
Revvity
RVTY
$12.9B
-10,123
Closed -$1.07M

Similar funds

Campbell & Co Investment Adviser's Q2 2025 Portfolio in Review

As of Q2 2025, Campbell & Co Investment Adviser held 1,532 positions worth $1.59B, up 22% from $1.3B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Campbell & Co Investment Adviser deployed $228M of net new capital in Q2 2025, opening 540 new positions and adding to 294 existing holdings. Its largest new stake was Johnson Controls International: 128,951 shares worth $13.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cardinal Health, an estimated $7.63M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2025 buy was Johnson Controls International: 128,951 shares worth $13.6M.
  • Campbell & Co Investment Adviser added most to Dover in Q2 2025, an estimated $7.63M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $7.63M.
  • Campbell & Co Investment Adviser fully exited Labcorp in Q2 2025, selling an estimated $8.73M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.1% of its $1.59B portfolio in Q2 2025.
  • Campbell & Co Investment Adviser opened 540 new positions and closed 432 in Q2 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 22% quarter-over-quarter to $1.59B.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.